Literature DB >> 7780395

Microbiology of osteomyelitis in diabetic foot infections.

L A Lavery1, M Sariaya, H Ashry, L B Harkless.   

Abstract

The objective of this report is to describe the bacterial pathogens in diabetic patients with osteomyelitis due to neuropathic foot ulcerations. The authors reviewed the records of 36 diabetic patients with osteomyelitis of the foot due to neuropathic ulceration. Intraoperative deep soft tissue and bone specimens were obtained from each patient. The mean age of patients was 56.7 years, and the mean duration of diabetes was 14.9 years. Streptococcus species (61%) and Staphylococcus aureus (47%) were the most common organisms identified. Gram-negative aerobes were found in 18 cultures (50%). Only five patients' cultures (14%) were identified with anaerobic pathogens. The average number of pathogens per patient was 2.25. The most common bacterial pathogens in bone infections in diabetics were Streptococcus species and Staphylococcus aureus. Anaerobes were uncommon.

Entities:  

Mesh:

Year:  1995        PMID: 7780395     DOI: 10.1016/S1067-2516(09)80103-8

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  14 in total

1.  Activity of Different Antistaphylococcal Therapies, Alone or Combined, in a Rat Model of Methicillin-Resistant Staphylococcus epidermidis Osteitis without Implant.

Authors:  S Albac; D Labrousse; D Hayez; N Anzala; D Bonnot; P Chavanet; E Aslangul; D Croisier
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

2.  The economic impact of Staphylococcus aureus infection in New York City hospitals.

Authors:  R J Rubin; C A Harrington; A Poon; K Dietrich; J A Greene; A Moiduddin
Journal:  Emerg Infect Dis       Date:  1999 Jan-Feb       Impact factor: 6.883

Review 3.  Musculoskeletal Infections in the Emergency Department.

Authors:  Daniel C Kolinsky; Stephen Y Liang
Journal:  Emerg Med Clin North Am       Date:  2018-09-06       Impact factor: 2.264

4.  Clinical significance of the isolation of Staphylococcus epidermidis from bone biopsy in diabetic foot osteomyelitis.

Authors:  Javier Aragón-Sánchez; Jose Luis Lázaro-Martínez; María José Hernández-Herrero; Yurena Quintana-Marrero; Juan J Cabrera-Galván
Journal:  Diabet Foot Ankle       Date:  2010-08-27

5.  Section's osseous slice biopsy during major amputation of lower extremity: preliminary results of prospective cohort study.

Authors:  Danguole Vaznaisiene; Rita Sulcaite; Astra Vitkauskiene; Arturas Spucis; Anatolijus Reingardas; Vytautas Kymantas; Kestutis Balanaska; Rolandas Sleivys; Linas Velicka; Juozas Belickas; Kristina Rysevaite-Kyguoliene; Dainius H Pauza; Aukse Mickiene; Eric Senneville
Journal:  BMC Infect Dis       Date:  2015-06-30       Impact factor: 3.090

6.  The diabetic rapid response acute foot team: 7 essential skills for targeted limb salvage.

Authors:  Ryan H Fitzgerald; Joseph L Mills; Warren Joseph; David G Armstrong
Journal:  Eplasty       Date:  2009-05-05

7.  Diagnosing diabetic foot osteomyelitis in patients without signs of soft tissue infection by coupling hybrid 67Ga SPECT/CT with bedside percutaneous bone puncture.

Authors:  Elisabeth Aslangul; Jocelyne M'bemba; Nadine Caillat-Vigneron; Sophie Coignard; Etienne Larger; Christian Boitard; Benjamin A Lipsky
Journal:  Diabetes Care       Date:  2013-03-20       Impact factor: 19.112

Review 8.  Charcot foot and ankle with osteomyelitis.

Authors:  Ryan Donegan; Bauer Sumpio; Peter A Blume
Journal:  Diabet Foot Ankle       Date:  2013-10-01

9.  Clinical features and outcome of bone and joint infections with streptococcal involvement: 5-year experience of interregional reference centres in the south of France.

Authors:  P Seng; M Vernier; A Gay; P-O Pinelli; R Legré; A Stein
Journal:  New Microbes New Infect       Date:  2016-04-13

10.  The microbiome of diabetic foot osteomyelitis.

Authors:  S A V van Asten; J La Fontaine; E J G Peters; K Bhavan; P J Kim; L A Lavery
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-15       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.